PsyIndex Weekly Update August 2, 2021 – August 6, 2021 The PsyIndex extended its move lower over the past week, even as two companies moved to senior stock exchanges. Investors will continue to keep an eye on several ongoing clinical trials, as well as private...
PsyIndex Weekly Update July 5, 2021 – July 9, 2021 The PsyIndex moved marginally lower last week, giving up some gains from the prior week. Meanwhile, investors continue to keep an eye on clinical results from many companies in the space. Market Performance...
PsyIndex Weekly Update June 21, 2021 – June 25, 2021 The PsyIndex extended its losses last week, although there were signs of a rebound toward the end of the week. With a combination of new public listings and favorable regulatory developments, the industry has...
PsyIndex Weekly Update June 14, 2021 – June 18, 2021 The PsyIndex gave up ground last week following the prior week’s robust gains. ATAI Life Sciences N.V. (NASDAQ: ATAI) began the new week on a positive note with a nearly 3% gain by mid-session while the...
atai Life Sciences B.V. began trading on the NASDAQ under the ticker symbol “ATAI” on June 18, 2021. atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The company was founded...
June 7, 2021 – June 11, 2021 The PsyIndex soared more than 15% last week as ATAI Life Sciences, a bellwether of the psychedelics industry, announced that it would look to raise up to $214 million, putting its value at up to $2.3 billion. Market Performance...
